Pfizer Inc financial data

Symbol
PFE on NYSE
Industry
Pharmaceutical Preparations
Location
66 Hudson Boulevard East, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 151 % +7.79%
Quick Ratio 27 % +19.5%
Debt-to-equity 134 % +24%
Return On Equity -0.33 % -101%
Return On Assets -0.14 % -101%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.67B shares +0.38%
Entity Public Float 207B USD -29.6%
Common Stock, Value, Issued 480M USD +0.42%
Weighted Average Number of Shares Outstanding, Basic 5.66B shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 5.7B shares -0.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 54.9B USD -41.1%
Revenue from Contract with Customer, Excluding Assessed Tax 50.9B USD -44.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.79B USD -106%
Income Tax Expense (Benefit) -1.54B USD -154%
Net Income (Loss) Attributable to Parent -309M USD -101%
Earnings Per Share, Basic -0.05 USD/shares -101%
Earnings Per Share, Diluted -0.05 USD/shares -101%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 719M USD -66.8%
Accounts Receivable, after Allowance for Credit Loss, Current 11B USD -10.7%
Inventory, Net 10.9B USD +14.2%
Other Assets, Current 4.37B USD -14.6%
Assets, Current 42.4B USD -15.3%
Other Long-term Investments 3.49B USD -2.19%
Property, Plant and Equipment, Net 18.8B USD +10.3%
Operating Lease, Right-of-Use Asset 2.92B USD -2.6%
Intangible Assets, Net (Excluding Goodwill) 62.8B USD +49.6%
Goodwill 69.3B USD +34.6%
Other Assets, Noncurrent 11.2B USD -13.6%
Assets 221B USD +13%
Accounts Payable, Current 5.59B USD -8.69%
Employee-related Liabilities, Current 2.19B USD -3.73%
Contract with Customer, Liability, Current 2.5B USD +43%
Liabilities, Current 40.5B USD +10.8%
Deferred Income Tax Liabilities, Net 931M USD -12.7%
Operating Lease, Liability, Noncurrent 2.63B USD +1.12%
Other Liabilities, Noncurrent 15.1B USD +16.2%
Liabilities 129B USD +36.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.76B USD +6.41%
Retained Earnings (Accumulated Deficit) 121B USD -7.46%
Stockholders' Equity Attributable to Parent 92.3B USD -8.61%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 92.6B USD -8.57%
Liabilities and Equity 221B USD +13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.09B USD -10.1%
Net Cash Provided by (Used in) Financing Activities -4.93B USD -78%
Net Cash Provided by (Used in) Investing Activities 1.73B USD -47.8%
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 9.56B shares +0.45%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14B USD -222%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 780M USD -64.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 415M USD -0.96%
Deferred Tax Assets, Valuation Allowance 1.74B USD +12.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 19B USD +28.6%
Operating Lease, Liability 3.15B USD -1.99%
Payments to Acquire Property, Plant, and Equipment 704M USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 223M USD -99.2%
Lessee, Operating Lease, Liability, to be Paid 3.82B USD -0.52%
Property, Plant and Equipment, Gross 35B USD +11.2%
Operating Lease, Liability, Current 527M USD -15%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +33.3%
Deferred Income Tax Expense (Benefit) -441M USD +26.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 671M USD +7.02%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -2.61B USD +20.3%
Preferred Stock, Shares Authorized 27M shares 0%
Unrecognized Tax Benefits 4.8B USD +6.85%
Operating Lease, Payments 744M USD +20.6%
Additional Paid in Capital 93B USD +0.92%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -135M USD -575%
Current Federal Tax Expense (Benefit) 1.32B USD -51.9%
Amortization of Intangible Assets 1.3B USD
Depreciation, Depletion and Amortization 1.74B USD +16.7%
Deferred Tax Assets, Net of Valuation Allowance 17.3B USD +30.4%
Share-based Payment Arrangement, Expense 525M USD -39.8%
Deferred State and Local Income Tax Expense (Benefit) -184M USD +40.6%
Interest Expense 2.68B USD +117%